Roberto Carlos Bravo González

4 Patents

• US123701462025

  Method of Producing a Delayed Release Drug Formulation

  Tillotts Pharma AG

  0 cites
• US123701472025

  Coatable Core for a Modified Release Drug Formulation

  Tillotts Pharma AG

  0 cites
• US123502462025

  Eflornithine and Sulindac, Fixed Dose Combination Formulation

  Cancer Prevention Pharmaceuticals, Inc.

  0 cites
• US119256132024

  Eflornithine and Sulindac, Fixed Dose Combination Formulation

  Cancer Prevention Pharmaceuticals, Inc.

  0 cites